Year: 2015
Type: dissertation
Abstract: Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease in adults. It is a spontaneous and relentlessly progressive disease caused by motor neuron degeneration. Previous studies based on familiar ALS (FALS) cases have identified mutations in several genes, such as SOD1, C9orf72, TDP43 or FUS/TLS, which cause the characteristic phenotypes in ALS2,4. However, more recently, susceptibility to develop neurodegenerative disorders has been associated with genetic modulators. This disease modifiers are thought to modulate the phenotype induced by the causal genes. Elongator Protein 3 (ELP3), a subunit of the RNA elongator complex, was found to correlate with ALS1. This protein is required for RNA processing, as part of the RNA polymerase II complex. Besides its role in RNA elongation, it is also involved in tRNA wobble nucleosides modification5,6. The role of ELP3 on RNA biology suggests it can be an important feature in the pathophysiology of this neurodegenerative disease. ELP3 role as an ALS modifier has not been investigated before, constituting the aim of this project. Therefore, modulation of ELP3 expression was investigated in the SOD1 mouse and in a C9orf72 repeat expansion zebrafish model. Additionally, the molecular mechanisms underlying the neuroprotective role of ELP3 were also assessed, with focus on ELP3 capacity to modify tRNAs at the wobble position. The results show that overexpression of human ELP3 in the SOD1G93A mouse prolonged the survival. Moreover, in a C9orf72 zebrafish model, human ELP3 overexpression partially prevented the axonopathy induced by the 66x(G4C2) repeat expansion. Finally, the molecular mechanism underlying the ELP3 protective role still remains to be clarified, since the data obtained were inconclusive.
Author: Lara Aletta Gruijs da Silva
Institution: University of Coimbra
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2602671109
